Study: Fractional Laser and Botox Combo Shows Promise for Pore Reduction
A single session of treatment with a fractional carbon dioxide laser followed by botulinum toxin type A was associated with significant reduction of facial pores in a pilot study presented at the American Society for Laser Medicine and Surgery (ASLMS) 43rd Annual Conference on Energy-based Medicine and Science in Baltimore. Enlarged facial pores are a common aesthetic concern, and fractional carbon dioxide (FxCO2) has shown success in minimizing pore size, but its use in combination with intradermal botulinum toxin type A (BTX-A) has not been examined, wrote Nattaporn Sampattavanich, MD, of Phramongkutklao Hospital, Bangkok, Thailand, and colleagues in an abstract presented at the annual conference of the American Society for Laser Medicine and Surgery. The researchers conducted a split-face pilot study of 15 adults with large facial pores. All participants underwent an initial session of FxCO2 applied to both cheeks, followed immediately by an injection of 16 units of BTX-A in one che